These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3030)

  • 1. [The pharmacotherapy of masked depression].
    Kielholz VP
    Wien Med Wochenschr; 1975 May; 125(21):327-9. PubMed ID: 3030
    [No Abstract]   [Full Text] [Related]  

  • 2. Second-generation antidepressants as research tools--some preliminary findings with clomipramine and maprotiline.
    Ridges AP
    Postgrad Med J; 1977; 53 Suppl 4():24-9. PubMed ID: 341107
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical responses in depressed patients in relation to plasma levels of tricyclic antidepressants and tyramine pressor response.
    Mulgirigama LD; Pare CM; Turner P; Wadsworth J; Witts DJ
    Postgrad Med J; 1977; 53 Suppl 4():155-9. PubMed ID: 341104
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe depression treatment: experience using maprotiline (Ludiomil) in combination with clomipramine (Anafranil).
    Ovuga E
    East Afr Med J; 1985 Feb; 62(2):79-81. PubMed ID: 4042927
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical and experimental experiences with maprotiline, clomipramine, sydnocarb and mefexamide in mentally-ill patients and in healthy persons].
    Zapletálek M; Hübsch T; Zbytovský J; Polácková J; Kindernayovä H
    Schweiz Arch Neurol Neurochir Psychiatr; 1977; 120(2):323-34. PubMed ID: 333568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects on suicidal ideation of mianserin, maprotiline and amitriptyline.
    Montgomery S; Cronholm B; Asberg M; Montgomery DB
    Br J Clin Pharmacol; 1978; 5 Suppl 1(Suppl 1):77S-80S. PubMed ID: 341948
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical and biochemical contributions on the effect of maprotiline and clomipramine in depressive states (preliminary observation)].
    Ravizza L
    Psychiatr Clin (Basel); 1979; 12(3):164-72. PubMed ID: 94169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of depression and its treatment on serum thyroxine.
    Goldberg IJ; Lawton K; Ridges AP
    Postgrad Med J; 1977; 53 Suppl 4():211-5. PubMed ID: 600897
    [No Abstract]   [Full Text] [Related]  

  • 9. Amine metabolism, thyroid function and response to clomipramine and maprotiline medication in depression.
    Ridges AP; Bishop FM; Lawton K; Goldberg IJ
    Postgrad Med J; 1980; 56 Suppl 1():37-41. PubMed ID: 6156444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyramine pressor responses and plasma levels during tricyclic antidepressant therapy.
    Mulgirigama LD; Pare CM; Turner P; Wadsworth J; Witts DJ
    Postgrad Med J; 1977; 53 Suppl 4():30-4. PubMed ID: 341108
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravenous maprotiline in severe and resistant primary depression: a double-blind comparison with clomipramine.
    Drago F; Motta A; Grossi E
    J Int Med Res; 1983; 11(2):78-84. PubMed ID: 6343154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined chlorimipramine and maprotiline therapy in therapy-resistant depressions].
    Soucek K
    Act Nerv Super (Praha); 1982 May; 24(2):88-9. PubMed ID: 7102229
    [No Abstract]   [Full Text] [Related]  

  • 13. Some observations on patient compliance in an antidepressive trial.
    Witts DJ; Mulgirigama D; Turner P; Pare CM
    Postgrad Med J; 1977; 53 Suppl 4():136-8. PubMed ID: 341102
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparison of the therapeutic effects of lofepramine and maprotiline in depression].
    Finke G; Wegener G
    MMW Munch Med Wochenschr; 1982 Mar; 124(12):301-3. PubMed ID: 6804813
    [No Abstract]   [Full Text] [Related]  

  • 15. Sleep deprivation and clomipramine in endogenous depression.
    Wirz-Justice A; Pühringer W; Hole G
    Lancet; 1976 Oct; 2(7991):912. PubMed ID: 62147
    [No Abstract]   [Full Text] [Related]  

  • 16. [Double-blind comparison of the effects of a new tricyclic antidepressant (Lofepramine) and a tetracyclic antidepressant (maprotiline)].
    Obermair W; Pöldinger W
    Int Pharmacopsychiatry; 1977; 12(2):65-71. PubMed ID: 330440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with maprotilin and maprotilin/clomipramine infusions in resistant depression.
    Zapletálek M; Zbytovský J; Kudrnová K
    Act Nerv Super (Praha); 1982 May; 24(2):73-6. PubMed ID: 7102227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of therapy-refractory depressions].
    Pöldinger W; Alac S; Krebs-Roubicek E
    Act Nerv Super (Praha); 1982 May; 24(2):55-62. PubMed ID: 6125075
    [No Abstract]   [Full Text] [Related]  

  • 19. Maprotiline and fluphenazine/nortriptyline in depression.
    O'Hara H; O'Hara J; Valle-Jones JC; McGhie RL; Brodie NH; Schiff AA
    Practitioner; 1978 Sep; 221(1323):419-23. PubMed ID: 366595
    [No Abstract]   [Full Text] [Related]  

  • 20. Maprotiline (Ludiomil, Ciba 34,276-BA) and imipramine in depressed outpatients: a double-blind clinical study.
    Singh AN; Saxena B; Gent M; Nelson HL
    Curr Ther Res Clin Exp; 1976 Apr; 19(4):451-62. PubMed ID: 816603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.